| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Valantine Hannah serves as a Director at CDNA and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 3 buys and 20 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Valantine Hannah's trades have earned a middling insider score of 51/100 across 12 rated trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -28.2%.
The biggest single holding is CDNA (~$911K) as Director. The recent filings there lean toward selling, a net 51,452 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | CDNA Caredx, Inc. | Director | Sale+OE | 28,779 | $36.15 | $1,040,243.12 | -44.0% | +60.4% | - | |
| Jun 23, 2026 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 5,004 | $68.25 | $341,523.72 | -35.1% | -3.0% | - | |
| Jun 15, 2026 | CDNA Caredx, Inc. | Director | Sell | 12,103 | $23.11 | $279,728.17 | -24.8% | +117.5% | - | |
| Mar 10, 2026 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 8,671 | $72.00 | $624,312.00 | -53.7% | -9.4% | - | |
| Feb 27, 2026 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 25,484 | $67.41 | $1,717,780.84 | -77.3% | +2.9% | - | |
| Nov 12, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 25,484 | $66.07 | $1,683,727.88 | -77.3% | +9.4% | - | |
| Jun 26, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 4,707 | $44.05 | $207,327.26 | -92.2% | +12.3% | +55.7% | |
| Jun 18, 2025 | CDNA Caredx, Inc. | Director | Sell | 10,570 | $19.16 | $202,565.59 | -21.3% | -25.5% | - | |
| Jun 10, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 4,292 | $40.00 | $171,680.00 | -70.9% | +35.4% | +68.1% | |
| Mar 6, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 12,875 | $32.58 | $419,499.69 | -87.9% | +18.0% | +102.8% |